Comprehensive management of ANOCA using lifestyle, pharmacological, and device-based therapies, delivered by multidisciplinary teams, can improve angina burden and quality of life.
Comprehensive, multidisciplinary management programs and collaborative research are critical for improving care and outcomes in patients with ANOCA.
Centers specializing in coronary function testing are critical to ensure a systematic approach to the diagnosis and treatment of angina with nonobstructive coronary arteries (ANOCA). Management leveraging lifestyle, pharmacology, and device-based therapeutic options for ANOCA can improve angina burden and quality of life in affected patients. Multidisciplinary care teams that can tailor and titrate therapies based on individual patient needs are critical to the success of comprehensive programs. As coronary function testing for ANOCA is more widely adopted, collaborative research initiatives will be fundamental to improve ANOCA care. These efforts will require standardized symptom assessments and data collection, which will propel future large-scale clinical trials.
Smilowitz et al. (Fri,) conducted a review in Angina with nonobstructive coronary arteries (ANOCA). Comprehensive management (lifestyle, pharmacology, and device-based therapies) was evaluated. Comprehensive management of ANOCA using lifestyle, pharmacological, and device-based therapies, delivered by multidisciplinary teams, can improve angina burden and quality of life.